From Name:
From Email:
To Name:
To Email:

Optional Message:

CFZ533, a new anti-CD40 mAB demonstrates comparable efficacy and better renal function versus tacrolimus in de-novo CNI-free kidney transplantation

from ATC

The aim of this study was to assess the potential of CFZ533 as primary immunosuppressant in a calcineurin(CNI)-free regimen in de novo kidney transplant (KTx) patients(pts). more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063